These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32097136)

  • 21. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes.
    Weinmann S; Janssen B; Gaebel W
    J Clin Psychiatry; 2004 Aug; 65(8):1099-105. PubMed ID: 15323596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics.
    Chen JJ; Chan HY; Chen CH; Gau SS; Hwu HG
    Pharmacopsychiatry; 2012 Mar; 45(2):64-71. PubMed ID: 22086749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.
    Fraguas D; Correll CU; Merchán-Naranjo J; Rapado-Castro M; Parellada M; Moreno C; Arango C
    Eur Neuropsychopharmacol; 2011 Aug; 21(8):621-45. PubMed ID: 20702068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
    Van Dorn RA; Andel R; Boaz TL; Desmarais SL; Chandler K; Becker MA; Howe A
    J Clin Psychiatry; 2011 Apr; 72(4):502-8. PubMed ID: 21527125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey.
    Kennedy J; Tien YY; Cohen LJ; Sclar DA; Liu D; Blodgett EG; Engle J
    Clin Ther; 2009 Dec; 31(12):2931-9. PubMed ID: 20110033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pimozide for schizophrenia or related psychoses.
    Mothi M; Sampson S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD001949. PubMed ID: 24194433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of long-acting injectable antipsychotics in delusional disorders with nonprominent hallucinations and without hallucinations.
    González-Rodríguez A; Molina-Andreu O; Penadés R; Bernardo M; Catalán R
    Int Clin Psychopharmacol; 2014 May; 29(3):177-80. PubMed ID: 24681811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Influencing Adherence to Antipsychotic Medications in Women with Delusional Disorder: A Narrative Review.
    González-Rodríguez A; Monreal JA; V Seeman M
    Curr Pharm Des; 2022; 28(15):1282-1293. PubMed ID: 35272589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second-generation antipsychotics in primary and secondary delusional parasitosis: outcome and efficacy.
    Freudenmann RW; Lepping P
    J Clin Psychopharmacol; 2008 Oct; 28(5):500-8. PubMed ID: 18794644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of second-generation antipsychotics with acute-phase schizophrenia.
    Hatta K; Sato K; Hamakawa H; Takebayashi H; Kimura N; Ochi S; Sudo Y; Asukai N; Nakamura H; Usui C; Kawabata T; Hirata T; Sawa Y
    Schizophr Res; 2009 Aug; 113(1):49-55. PubMed ID: 19553086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naturalistic, retrospective comparison between second-generation antipsychotics and depot neuroleptics in patients affected by schizophrenia.
    Marchiaro L; Rocca P; LeNoci F; Longo P; Montemagni C; Rigazzi C; Bogetto F
    J Clin Psychiatry; 2005 Nov; 66(11):1423-31. PubMed ID: 16420080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: A nationwide population-based cohort study.
    Chen VC; Liao YT; Lai TJ; Lane HY; Shao WC; Dewey M; Lee CT; Lu ML
    Schizophr Res; 2015 Dec; 169(1-3):406-411. PubMed ID: 26481616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipsychotic response in delusional disorder and schizophrenia: a prospective cohort study.
    González-Rodríguez A; Catalán R; Penadés R; Ruiz V; Torra M; Bernardo M
    Actas Esp Psiquiatr; 2016 Jul; 44(4):125-35. PubMed ID: 27388104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seventy Years of Treating Delusional Disorder with Antipsychotics: A Historical Perspective.
    González-Rodríguez A; Monreal JA; Natividad M; Seeman MV
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36552037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in the treatment of delusional disorder.
    Manschreck TC; Khan NL
    Can J Psychiatry; 2006 Feb; 51(2):114-9. PubMed ID: 16989110
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.